# Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients

> **NCT02949154** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 65 (actual)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02949154
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949154, "Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02949154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*